Epidemiology of breast cancer in connecticut women

Connecticut Medicine

Volumn 63, Issue 1, 1999, Pages 7-16

  Polednak, Anthony P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; FEMALE; HUMAN; INCIDENCE; MIDDLE AGED; RISK FACTOR; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CONNECTICUT; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; RISK FACTORS;

EID: 0032604050     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1997. CA - A Cancer J Clinicians 1997; 47:5-27.
2. Ries LAG, Kosary CL, Hankey BF, et al: (eds.) SEER Cancer Statistics Review, 1973-1994. Bethesda MD: National Cancer Institute, NIH Public. No. 97-2789, 1997.
3. Shambaugh E: Stat bite: Accuracy of SEER data. J Natl Cancer Inst 1991; 83:1369.
4. Zippin C, Lum D, Hankey BF: Completeness of hospital cancer cases reporting from the SEER Program of the NCI. Cancer 1995; 76:2343-50.
5. Thomas DB: Breast cancer in men. Epidemiol Rev 1993; 15: 220-31.
6. Horn-Ross PL: Multiple primary cancers including the breast. Epidemiol Rev 1993; 15:169-76.
7. Roubidou MA, Helvie MA, Wilson TE, et al: Women with breast cancer: Histologic findings in the contralateral breast. Radiology 1997; 203:691-4.
8. Volk N, Pompe-Kirn V: Second primary cancers in breast cancer patients in Slovenia. Cancer Causes Control 1997; 8:764-70.
9. Bodian CA: Benign breast diseases, carcinoma in situ, and breast cancer risk. Epidemiol Rev 1993; 15:177-87.
10. van Dongen JA, Harris JR, Peterse JL, et al: In-situ breast cancer: The EORTC consensus meeting. Lancet 1989; 2:25-7.
11. Ernster VL, Barclay J:. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: A dilemma. Mongr Natl Cancer Inst 1997; 22:151-6.
12. Hoskins KF, Stopfer JE, Calzone KA: Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. JAMA 1995; 273:577-85.
13. Schrag D, Kuntz KM, Garber JE, et al: Decision analysis - effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 1997; 336:1465-71.
14. Madigan MP, Ziegler RG, Benichou J, et al: Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 1995; 87:1681-5.
15. Burke W, Press N, Pinsky L: Breast carcinoma from a primary care perspective. Cancer 1997; 80(Suppl):621-6.
16. Pike MC, Spicer DV, Dahmoush L, et al: Estrogens, progestogens, normal breast cell proliferation and breast cancer risk. Epidemiol Rev 1993; 15:17-35.
17. Baquet CR, Horm JW, Gibbs, et al: Socioeconomic factors and cancer incidence among blacks and whites. J Natl Cancer Inst 1991; 83:551-7.
18. Leon DA, Carpenter LM, Breeders MJM, et al: Breast cancer in Swedish women before age 50: Evidence of a dual effect of completed pregnancy. Cancer Causes Contr 1995; 6:283-91.
19. Michels KB, Willett WC, Rosner BA, et al: Prospective assessment of breastfeeding and breast cancer incidence among 89,887 women. Lancet 1996; 347:431-6.
20. Thomas HV, Reeves GK, Key TJA: Endogenous estrogen and postmenopausal breast cancer: A quantitative review. Cancer Causes Contr 1997; 8:922-8.
21. Calle EE, Heath CW Jr, Miracle-McMahill HL, et al: Breast cancer hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 1996; 347:1713-27.
22. Hankinson SE, Colditz GA, Manson JE, et al: A prospective study of oral contraceptive use and risk of breast cancer (Nurses' Health Study, United States). Cancer Causes Contr 1997; 8:65-72.
23. Brinton LA, Schairer C: Estrogen replacement therapy and breast cancer. Epidemiol Rev 1993; 15:66-79.
24. Colditz GA, Hankinson SE, Hunter DJ, et al: The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1997; 332:1589-93.
25. Laya MB, Larson EB, Taplin SH, White E: Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst 1996; 88:643-9.
26. Harvey JA, Pinkerton JV, Herman CR: Short-term cessation of hormone-replacement therapy and improvement in mammographic specificity. J Natl Cancer Inst 1997; 89:1623-5.
27. Davidson NE: Hormone-replacement therapy - breast versus heart versus bone. N Engl J Med 1997; 322:1638-9.
28. Hunter DJ, Willett WC: Diet, body size and breast cancer. Epidemiol Rev 1993; 15:110-32.
29. van den Brandt PA, Dirx MJM, Ronckers CM, van den Hoogen P, Goldbohm RA: Height, weight, weight change, and postmenopausal breast cancer risk: The Netherlands cohort study. Cancer Causes Contr 1997; 8:39-47.
30. Smigel K: International group releases first set of global dietary recommendations. JNCI 1997; 89:1570-1.
31. Thune I, Brenn T, Lund E, Gaard M: Physical activity and the risk of breast cancer. N Engl J Med 1997; 336:1269-75.
32. McTiernan A: Exercise and breast cancer - Time to get moving? N Engl J Med 1997; 336:1311-2.
33. Rosenberg L, Metzger LS, Palmer JR: Alcohol consumption and risk of breast cancer: A review of the epidemiologic evidence. Epdemiol Rev 1993; 15:133-44).
34. Swanson CA, Coates RJ, Malone KE, et al: Alcohol consumption and breast cancer risk among women under age 45 years. Epidemiology 1997; 8:231-7.
35. Ambrosone CB, Freudenheim JL, Graham S, et al: Cigarette smoking, N-acetyltransfase 2 genetic polymorphisms, and breast cancer risk. JAMA 1996; 276:1494-501.
36. Lin HJ: Smokers and breast cancer: 'Chemical individuality' and cancer predisposition. JAMA 1996; 276:1511-2.
37. Calle EE, Miracle-McMahill HL, Thun MJ, et al: Cigarette smoking and risk of fatal breast cancer. Am J Epidemiol 1994; 139:1001-7.
38. Parish DC: Another indication for screening and early intervention: Problem drinking. JAMA 1997; 277:1079-80.
39. Boice JD Jr, Lubin JH: Occupational and environmental radiation and cancer. Cancer Causes Contr 1997; 8:309-22.
40. Campion EW: Power lines, cancer, and fear. W Engl J Med 1997; 337:44-6.
41. Valberg PA: Radio frequency radiation (RFR): The nature of exposure and carcinogenic potential. Cancer Causes Contr 1997; 8:323-32.
42. Tynes T, Hannevik M, Andersen A, et al: Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Contr 1996; 6:197-204.
43. Dich J, Zahm SH, Hanberg A, et al: Pesticides and cancer. Cancer Causes Contr 1997; 8:420-43.
44. Kulldorff M, Feuer EJ, Miller BA, Freedman LS: Breast cancer clusters in the Northeast United States: A geographic analysis. Am J Epidemiol 1997; 146:161-70.
45. Laden F, Spiegelman D, Neas LM, et al: Geographic variation in breast cancer incidence rates in a cohort of U.S. women. J Natl Cancer Inst 1997; 89:1373-8.
46. Wynder EL, Cohen LA, Muscat JE, et al: Breast cancer: Weighing the evidence for a promoting role of dietary fat. J Natl Cancer Inst 1997; 89:766-75.
47. Bush TL, Helzlsouer KJ: Tamoxifen for the primary prevention of breast cancer: A review and critique of the concept and trial. Epidemiol Rev 1993; 15:233-43.
48. Braunwlad E. Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities. N Engl J Med 1997; 337:1360-9.
49. Polednak AP: Estimating breast cancer incidence in Hispanic women in Connecticut. Ethnic Health 1996; 1:229-36.
50. Polednak AP: Trends in cancer incidence in Connecticut, 1935-1991. Cancer 1994; 74:2863-72.
51. Polednak AP: Trends in cancer incidence in Connecticut. Conn Med 1997; 61:211-8.
52. Polednak AP: Surveillance of cancer incidence in Connecticut by county and town, 1989-1991. Conn Med 1995; 59:323-30.
53. Berg JW, Hutter RVP: Breast cancer. Cancer 1995; 75(Suppl): 257-69.
54. Yeatman TJ, Lyman GH, Smith SK, et al: Bilaterality and recurrence rates for lobular breast cancer: Considerations for treatment. Ann Surg Oncol 1997; 4:198-202.
55. Donegan WL: Tumor-related prognostic factors for breast cancer. CA - A Cancer J Clinicians 1997; 47:28-51.
56. Jones BA, Kasl SV, Curnen MGM, et al: Severe obesity as an explanatory factor for the black/white difference in stage at diagnosis of breast cancer. Am J Epidemiol 1997; 146:394-404.
57. Jones BA, Kasl SV, Curnen MGM, et al: Can mammography screening explain the race difference in stage at diagnosis of breast cancer? Cancer 1995; 75:2103-13.
58. Chang SW, Kerlikowse K, Napoles-Springer A, et al: Racial differences in timeliness of follow-up after abnormal screening mammogram. Cancer 1996; 78:1395-402.
59. Henderson IC, Patek AJ: Are breast cancers in young women qualitatively distinct? Lancet 1997; 349:1488.
60. National Institutes of Health Consensus Development Panel: National Institutes of Health Consensus Development Conference Statement: Breast cancer screening for women ages 40-49, January 21-23, 1997. Monogr NCI No. 22, 1997.
61. National Cancer Institute: Questions and answers about mammography screening. Cancer Facts July 2, 1997.
62. Black WC, Nease RF Jr, Tosteson ANA: Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 1995; 87:720-31.
63. Adams M: Connecticut Behavioral Health Risks, 1990. State of Connecticut, Department of Public Health. Hartford Connecticut.
64. Adams M: Connecticut Behavioral Health Risks. State of Connecticut, Department of Public Health. Hartford Conn., 1995.
65. Zapka JG, Hosmer D, Costanza ME, et al: Changes in mammography use: Economic, need, and service factors. Am J Public Health 1992; 82:1345-351.
66. Taplin SH, Mandelson MT, Anderman C, et al: Mammography diffusion and trends in late-stage breast cancer: Evaluating outcomes in a population. Cancer Epidemiol Biomarkers Prevent 1997; 6:625-31.
67. Polednak AP, Flannery JT: Late-stage breast cancer in Connecticut's three largest cities. Conn Med 1994; 58:261-4.
68. Polednak AP: Using a population-based cancer registry in planning breast cancer screening programs in urban neighborhoods. J Registry Management 1996; 23:179-82.
69. Ballard-Barash R, Taplin SH, Yankaskas BC: Breast cancer surveillance consortium: A national mammography screening and outcomes database. Am J Radiol 1997; 169:1001-8.
70. National Cancer Institute: Cancer death rate declined for the first time ever. Cancer Facts 1997; 10:1-10.
71. Amadeo FA, Bower CE, Mueller LM: State of Connecticut: One hundred and forty-eight registration report, 1995. Connecticut Department of Public Health. Hartford, Conn.
72. Polednak AP: Estimating the prevalence of cancer in the United States. Cancer 1997; 80:136-41.